News
Patient 5 still cancer-free 18 months after single treatment
Patient five has demonstrated no tumour recurrence, progression or presence of NMIBC disease at the 90, 180, 270, 360 and now 540 days post treatment clinical and cystoscopy assessment. More information can be found in the Theralase press release.
